Literature DB >> 26997980

Characterization of Polyamidoamino (PAMAM) Dendrimers Using In-Line Reversed Phase LC Electrospray Ionization Mass Spectrometry.

John R Lloyd1, P Suresh Jayasekara2, Kenneth A Jacobson1.   

Abstract

Generation 3 (G3) PAMAM dendrimers are symmetrical, highly branched polymers widely reported in the scientific literature as therapeutic agents themselves or as carrier scaffolds for various therapeutic agents. A large number of analytical techniques have been applied to study PAMAM dendrimers, but one that has been missing is in-line reversed phase LC electrospray ionization mass spectrometry (RP/LC/ESI/MS). To translate PAMAM dendrimers into therapeutic agents, a better understanding of their purity, stability and structure is required, and in-line RP/LC/ESI/MS is widely applied to all three of these analytical questions. In this study, we developed a robust in-line RP/LC/ESI/MS method for assessing stability, purity and structure of the G3 PAMAM dendrimers, and we also examined the reasons why previous attempts at method development failed. Using the RP/LC/ESI/MS method we uncovered several unique aspects of the chemistry of G3 PAMAM dendrimers. They are interconverted between two isomeric forms by dialysis, and under higher concentration levels there is an inter-molecular displacement reaction resulting, which degrades PAMAM dendrimers. Purification of G3 dendrimers by RP/LC was also previously unreported; so we slightly modified the LC/MS method for isolating individual components from a complex dendrimer mixture. Thus, we have developed a robust, comprehensive method for characterizing PAMAM dendrimers and their degradation.

Entities:  

Year:  2015        PMID: 26997980      PMCID: PMC4792036          DOI: 10.1039/C5AY01995H

Source DB:  PubMed          Journal:  Anal Methods        ISSN: 1759-9660            Impact factor:   2.896


  14 in total

1.  Comprehensive profiling of the complex dendrimeric contrast agent Gadomer using a combined approach of CE, MS, and CE-MS.

Authors:  Kai Vetterlein; Ulf Bergmann; Karlo Büche; Martina Walker; Jochen Lehmann; Michael W Linscheid; Gerhard K E Scriba; Michael Hildebrand
Journal:  Electrophoresis       Date:  2007-08       Impact factor: 3.535

Review 2.  Refolding of proteins from inclusion bodies: rational design and recipes.

Authors:  Anindya Basu; Xiang Li; Susanna Su Jan Leong
Journal:  Appl Microbiol Biotechnol       Date:  2011-08-07       Impact factor: 4.813

Review 3.  Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications.

Authors:  R M Kannan; E Nance; S Kannan; D A Tomalia
Journal:  J Intern Med       Date:  2014-07-31       Impact factor: 8.989

4.  Quantitative analysis of generation and branch defects in G5 poly(amidoamine) dendrimer.

Authors:  Mallory A van Dongen; Ankur Desai; Bradford G Orr; James R Baker; Mark M Banaszak Holl
Journal:  Polymer (Guildf)       Date:  2013-07-19       Impact factor: 4.430

5.  Isolation and characterization of dendrimers with precise numbers of functional groups.

Authors:  Douglas G Mullen; Emilee L Borgmeier; Ankur M Desai; Mallory A van Dongen; Mark Barash; Xue-min Cheng; James R Baker; Mark M Banaszak Holl
Journal:  Chemistry       Date:  2010-09-17       Impact factor: 5.236

6.  Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model.

Authors:  Sujatha Kannan; Hui Dai; Raghavendra S Navath; Bindu Balakrishnan; Amar Jyoti; James Janisse; Roberto Romero; Rangaramanujam M Kannan
Journal:  Sci Transl Med       Date:  2012-04-18       Impact factor: 17.956

7.  Click modification in the N6 region of A3 adenosine receptor-selective carbocyclic nucleosides for dendrimeric tethering that preserves pharmacophore recognition.

Authors:  Dilip K Tosh; Khai Phan; Francesca Deflorian; Qiang Wei; Lena S Yoo; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2012-01-11       Impact factor: 4.774

8.  Adsorption of poly(amido amine) (PAMAM) dendrimers on silica: importance of electrostatic three-body attraction.

Authors:  Brian P Cahill; Georg Papastavrou; Ger J M Koper; Michal Borkovec
Journal:  Langmuir       Date:  2007-12-12       Impact factor: 3.882

9.  Optimization of reversed-phase peptide liquid chromatography ultraviolet mass spectrometry analyses using an automated blending methodology.

Authors:  Asish B Chakraborty; Scott J Berger
Journal:  J Biomol Tech       Date:  2005-12

10.  Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest.

Authors:  Manoj K Mishra; Claude A Beaty; Wojciech G Lesniak; Siva P Kambhampati; Fan Zhang; Mary A Wilson; Mary E Blue; Juan C Troncoso; Sujatha Kannan; Michael V Johnston; William A Baumgartner; Rangaramanujam M Kannan
Journal:  ACS Nano       Date:  2014-02-19       Impact factor: 15.881

View more
  4 in total

Review 1.  Hybrid Nanosystems for Biomedical Applications.

Authors:  Joshua Seaberg; Hossein Montazerian; Md Nazir Hossen; Resham Bhattacharya; Ali Khademhosseini; Priyabrata Mukherjee
Journal:  ACS Nano       Date:  2021-01-26       Impact factor: 18.027

2.  Chemical characterization (LC-MS-ESI), cytotoxic activity and intracellular localization of PAMAM G4 in leukemia cells.

Authors:  R Flores-Mejía; M J Fragoso-Vázquez; L G Pérez-Blas; A Parra-Barrera; S S Hernández-Castro; A R Estrada-Pérez; J Rodrígues; E Lara-Padilla; A Ortiz-Morales; J Correa-Basurto
Journal:  Sci Rep       Date:  2021-04-15       Impact factor: 4.379

3.  In silico and in vivo studies of gp120-HIV-derived peptides in complex with G4-PAMAM dendrimers.

Authors:  Rodríguez-Fonseca Rolando Alberto; Bello Martiniano; Rojas-Hernández Saúl; García-Machorro Jazmín; Gutiérrez-Sánchez Mara; Estrada-Pérez Alan Rubén; Fragoso-Vázquez Manuel Jonathan; Méndez-Méndez Juan Vicente; Correa-Basurto José
Journal:  RSC Adv       Date:  2020-05-27       Impact factor: 4.036

4.  PAMAM Dendrimer Nanomolecules Utilized as Drug Delivery Systems for Potential Treatment of Glioblastoma: A Systematic Review.

Authors:  Michael Fana; John Gallien; Bhairavi Srinageshwar; Gary L Dunbar; Julien Rossignol
Journal:  Int J Nanomedicine       Date:  2020-04-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.